Search

Search Constraints

You searched for: Author/Creator Gobom, Johan

Search Results

21. Choroid plexus volume is associated with levels of CSF proteins predominantly expressed by the choroid plexus in non‐demented individuals with AD pathophysiology. (20th December 2022)

22. Corrigendum to "The amyloid-beta degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease" [Neurosci. Lett. 573 (2014) 7–12]. (10th July 2015)

23. Corrigendum to "The amyloid-beta degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease" [Neurosci. Lett. 573 (2014) 7–12]. (10th July 2015)

24. CSF Proteome Changes Depend on APOE Genotype in Prodromal AD. (20th December 2022)

25. CSF proteomic profiling of mild cognitive impairment individuals with suspected non‐Alzheimer's disease pathophysiology: Developing topics. (7th December 2020)

26. Decorin is an early CSF biomarker of Alzheimer's Aβ amyloidosis. (31st December 2021)

27. Derivation of cut‐offs for plasma neurofilament light in clinical routine using healthy subjects aged between 5‐90. (20th December 2022)

28. Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition. Issue 1 (6th May 2022)

29. Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years. Issue 4 (4th July 2022)

30. Ex vivo18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway. Issue 1 (December 2017)